Cite

HARVARD Citation

    Abel, S. et al. (2019). Establishing a histology-specific biologically effective dose threshold for lung stereotactic ablative radiotherapy (SABR): Is ≥100 Gy10 enough?. Lung cancer. pp. 169-174. [Online]. 
  
Back to record